These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. CRISPR-Cas9-mediated gene editing of the BCL11A enhancer for pediatric β Fu B; Liao J; Chen S; Li W; Wang Q; Hu J; Yang F; Hsiao S; Jiang Y; Wang L; Chen F; Zhang Y; Wang X; Li D; Liu M; Wu Y Nat Med; 2022 Aug; 28(8):1573-1580. PubMed ID: 35922667 [TBL] [Abstract][Full Text] [Related]
43. Ten Years of Routine α- and β-Globin Gene Sequencing in UK Hemoglobinopathy Referrals Reveals 60 Novel Mutations. Henderson SJ; Timbs AT; McCarthy J; Gallienne AE; Proven M; Rugless MJ; Lopez H; Eglinton J; Dziedzic D; Beardsall M; Khalil MS; Old JM Hemoglobin; 2016; 40(2):75-84. PubMed ID: 26635043 [TBL] [Abstract][Full Text] [Related]
44. [Optimization of β-globin Stable Expression Using the Third Generation Lentiviral Vector for β-thalassemia Therapy]. Yu Z; Tong S; Bai Y; Zhong XS Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):844-850. PubMed ID: 35680815 [TBL] [Abstract][Full Text] [Related]
45. CRISPR/Cas9, a promising approach for the treatment of β-thalassemia: a systematic review. Khiabani A; Kohansal MH; Keshavarzi A; Shahraki H; Kooshesh M; Karimzade M; Gholizadeh Navashenaq J Mol Genet Genomics; 2023 Jan; 298(1):1-11. PubMed ID: 36403178 [TBL] [Abstract][Full Text] [Related]
46. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. Frangoul H; Altshuler D; Cappellini MD; Chen YS; Domm J; Eustace BK; Foell J; de la Fuente J; Grupp S; Handgretinger R; Ho TW; Kattamis A; Kernytsky A; Lekstrom-Himes J; Li AM; Locatelli F; Mapara MY; de Montalembert M; Rondelli D; Sharma A; Sheth S; Soni S; Steinberg MH; Wall D; Yen A; Corbacioglu S N Engl J Med; 2021 Jan; 384(3):252-260. PubMed ID: 33283989 [TBL] [Abstract][Full Text] [Related]
47. Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing. Li C; Psatha N; Sova P; Gil S; Wang H; Kim J; Kulkarni C; Valensisi C; Hawkins RD; Stamatoyannopoulos G; Lieber A Blood; 2018 Jun; 131(26):2915-2928. PubMed ID: 29789357 [TBL] [Abstract][Full Text] [Related]
49. CRISPR/Cas9 system and its applications in human hematopoietic cells. Hu X Blood Cells Mol Dis; 2016 Nov; 62():6-12. PubMed ID: 27736664 [TBL] [Abstract][Full Text] [Related]
50. [Research Progress on Gene Therapy for β-thalassemia---Review]. Hong WC; Fang JP; Xu LH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1676-1679. PubMed ID: 34627461 [TBL] [Abstract][Full Text] [Related]
51. Design Principles of a Novel Construct for HBB Gene-Editing and Investigation of Its Gene-Targeting Efficiency in HEK293 Cells. Lotfi M; Ashouri A; Mojarrad M; Mozaffari-Jovin S; Abbaszadegan MR Mol Biotechnol; 2024 Mar; 66(3):517-530. PubMed ID: 37266832 [TBL] [Abstract][Full Text] [Related]
52. Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemia. Suragani RN; Cawley SM; Li R; Wallner S; Alexander MJ; Mulivor AW; Gardenghi S; Rivella S; Grinberg AV; Pearsall RS; Kumar R Blood; 2014 Jun; 123(25):3864-72. PubMed ID: 24795345 [TBL] [Abstract][Full Text] [Related]
53. Induction of therapeutic levels of HbF in genome-edited primary β Mingoia M; Caria CA; Ye L; Asunis I; Marongiu MF; Manunza L; Sollaino MC; Wang J; Cabriolu A; Kurita R; Nakamura Y; Cucca F; Kan YW; Marini MG; Moi P Br J Haematol; 2021 Jan; 192(2):395-404. PubMed ID: 33216968 [TBL] [Abstract][Full Text] [Related]
58. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator. Malik P; Arumugam PI; Yee JK; Puthenveetil G Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671 [TBL] [Abstract][Full Text] [Related]
59. Efficient CRISPR-Cas9-based genome editing of β-globin gene on erythroid cells from homozygous β Cosenza LC; Gasparello J; Romanini N; Zurlo M; Zuccato C; Gambari R; Finotti A Mol Ther Methods Clin Dev; 2021 Jun; 21():507-523. PubMed ID: 33997100 [TBL] [Abstract][Full Text] [Related]
60. Relative and Absolute Quantification of Aberrant and Normal Splice Variants in Patsali P; Papasavva P; Christou S; Sitarou M; Antoniou MN; Lederer CW; Kleanthous M Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933098 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]